Showing results (2441-2450 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|April 29, 2006
Fresh frozen plasma and platelet concentrates may increase plasma anti-diphtheria toxin IgG concentrations: Implications for diphtheria fusion protein therapyPhilip D Hall, Debajyoti Sinha, Arthur E FrankelCancer Immunology, Immunotherapy : CII|May 6, 2006
Immune enhancement and anti-tumour activity of IL-23Jing-Sheng Hao, Bao-En ShanCancer Immunology, Immunotherapy : CII|February 27, 2004
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasiaSophie Hallez, Philippe Simon, Frédéric Maudoux, et al.Cancer Immunology, Immunotherapy : CII|February 27, 2004
Detection of circulating tumor lysate-reactive CD4+ T cells in melanoma patientsMorten Ladekarl, Ralf Agger, Charlotte C Fleischer, et al.Cancer Immunology, Immunotherapy : CII|March 3, 2004
alpha-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cellsLalitha V Ramanathapuram, James J Kobie, David Bearss, et al.Cancer Immunology, Immunotherapy : CII|September 28, 2004
Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53José Manuel Rojas, Stephanie E B McArdle, Roger B V Horton, et al.Cancer Immunology, Immunotherapy : CII|September 28, 2004
Rituximab induces different but overlapping sets of genes in human B-lymphoma cell linesElena Cittera, Chiara Onofri, Maria D'Apolito, et al.Cancer Immunology, Immunotherapy : CII|September 28, 2004
Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in ratsClaudia Maria Goetz, Walter Rachinger, Markus Decker, et al.Cancer Immunology, Immunotherapy : CII|September 28, 2004
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancerP J Russell, K T Ow, P N Tam, et al.Cancer Immunology, Immunotherapy : CII|September 21, 2004
NK cell activation and tumor infiltration are involved in the antitumor mechanism of VirulizinMing Yu Cao, Yoon Lee, Ningping Feng, et al.Pageof 652